Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05441592 · ClinicalTrials.gov registry record · Phase 4
A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 107
- Enrollment target
NCT05441592 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 107 participants.
The verdict
NCT05441592, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 107 participants
- Enrollment target
Study Summary
This trial is being completed to evaluate the safety and efficacy of topical tranexamic acid use in preventing hematomas in routine breast plastic surgery operations.
Interventions
- DRUG Tranexamic acid injection
- OTHER No additional irrigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2024-10-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05441592
The ClinicalTrials.gov registry entry for NCT05441592 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic acid injection is the first listed.
NCT05441592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05441592 about?
NCT05441592 is a clinical study titled "A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery". This trial is being completed to evaluate the safety and efficacy of topical tranexamic acid use in preventing hematomas in routine breast plastic surgery operations.
What is the current status of trial NCT05441592?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 107 participants. The study started on 2022-08-15. Estimated completion is 2024-10-22.
What interventions are being tested in trial NCT05441592?
The interventions under investigation include: Tranexamic acid injection (DRUG), No additional irrigation (OTHER).
Who is sponsoring clinical trial NCT05441592?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.